发明名称 Process for preparing enantiomer piperazine derivative
摘要 <p>In the present invention there is disclosed a process for preparing a substantially pure enantiomer piperazine derivative of the general formula IX, in which X represents oxygen, sulfur, the group NH, N-alkyl containing 1 to 4 carbon atoms or CHi2, Yi1, Yi2 and Yi3 each represents hydrogen, a halogen alkyl containing 1 to 4 carbon atoms , alkoxyl containing 1 to 4 carbon atoms, haloalkyl containing 1 to 4 carbon atoms a nitro group or a cyano group, A represents alkylene containing 2 to 4 carbon atoms, B represents an optionally substituted phenyl or heterocyclic group and C*-atom is in R-configuration. The invented process is characterized in that (a) a racemic alcohol of the general formula I is acylated with an acylating agent in the presence of an enzyme exhibiting stereoselective esterification activity, the non-esterified compound is separated from the formed ester that is subsequently subjected to hydrolysis and a waste undesired alcohol enantiomer is then converted under basic conditions to the starting racemic alcohol that is brought again back into reaction, (b) a free hydroxy group of so obtained alcohol enantiomer is protected, (c) a nitro group of the product is reduced to an amino group, (d) the amino compound is then converted to a piperazine compound, (e) said piperazine compound is subsequently subjected to derivatization and (f) from the obtained compound the protecting group is cleaved.</p>
申请公布号 CZ286162(B6) 申请公布日期 2000.01.12
申请号 CZ19970002905 申请日期 1997.09.15
申请人 DUPHAR INTERNATIONAL RESEARCH B.V. 发明人 BUIZER NICOLAAS;KRUSE CHRIS G.;VAN DER LAAN MELLE;LANGRAND GEORGES;VAN SCHARRENBURG GUSTAAF J. M.;SNOEK MARIA C.
分类号 C12P41/00;C07D;C07D265/36;C07D291/08;C07D311/04;C07D311/58;C07D311/76;C07D319/16;C07D319/20;C07D327/06;C07D405/04;C07D405/10;C07D405/12;C07D405/14;C07D407/12;C07D411/10;C07D413/04;C07D413/10;C07D413/14;C07D419/10;C07F7/10;C12N9/14;C12P;C12P17/00;C12P17/06;C12P17/14;C12P17/16;C12P17/18;(IPC1-7):C12P41/00 主分类号 C12P41/00
代理机构 代理人
主权项
地址